Based on AbbVie’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $13.34 billion and a net profit of $1.29 billion. In comparison, last year the ...

Amgen (AMGN) recently declared a $2.38 dividend per share, continuing its practice of rewarding shareholders, which aligns ...

THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN ) today announced that its Board of Directors declared a $2.38 per share dividend for the third quarter of 2025. The dividend ...

A tough week for the stock market left a scattering of top stocks near buy points. Palantir, Disney, Caterpillar are among ...

Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

During the second quarter of 2025, the Company repurchased shares of its common stock and recorded the cost of the shares, or $1.070 billion, as Treasury Stock. As of June 30, 2025, $2.814 billion ...

Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...

President Donald Trump gestures on the day he signs an executive order on prescription drug pricing during a press conference ...

Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement ...

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...